- Home
- /
- Treatment
- /
- Page 52
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Cannabidiol | Graft Versus Host Disease | Talent biotechs Ltd.;14 - 18 Baruch Hirsch St., Bnei Brak 5120206; | July 14, 2015 | |
3-(4-(1,5-Napthrydine)-Imidazole[1,2-a]pyridine-7-(1-phenyl-4-(1-(4-methyl piperazine) | Fibrodysplasia ossificans progressiva | La Jolla Pharmaceutical Company, Inc.;10182 Telesis Court, Suite 600;San Diego, California, 92121 | July 14, 2015 | |
3-(4-(8-fluoroquinoline)-Imidazole[1,2-a]pyridine-7-(1-phenyl-4-(1-(4-methyl piperazine) | Fibrodysplasia ossificans progressiva | La Jolla Pharmaceutical Company, Inc.;10182 Telesis Court, Suite 600;San Diego, California, 92121 | July 14, 2015 | |
DPX-Survivac | Ovarian cancer | Immunovaccine Technologies, Inc.;1344 Summer Street, Halifax, Nova Scotia B3H; | July 14, 2015 | |
Anisina | Neuroblastoma | Novogen Ltd;16-20 Edgeworth David Avenue, Hornsbsy, NSW 2077; | July 14, 2015 | |
Nano-diamino-tetraiodothyroacetic acid | Glioblastoma | NanoPharmaceuticals, LLC;1 Discovery Place;Rensselaer, New York, 12144 | July 9, 2015 | |
1-(4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide | Multiple myeloma | Cleave Biosciences, Inc.;866 Malcolm Road, Suite 100;Burlingame, California, 94010 | July 8, 2015 | |
Propranolol and etodolac | Glioma | Vicus Therapeutics, LLC;55 Madison Avenue, Suite 400;Morristown, New Jersey, 07960 | July 8, 2015 | |
ANA-conjugated dactunomycin nanoemulsion | Ewing sarcoma | NanoSmart Pharmaceuticals, Inc.;27071 Cabot Road, Suite 104;Laguna Hills, California, 92653 | July 7, 2015 | |
Sarizotan | Rett like syndrome | Newron Pharmaceuticals US, Inc.;89 Headquarter Plaza North, Suite 1438;Morristown, New Jersey, 07960 | July 7, 2015 | |
Gemcitabine ready-to-use | Pancreatic Cancer | Sun Pharmaceutical Industries Ltd.;Acme Plaza, Andheri (East), Mumbai 400059; | June 24, 2015 | |
Gemcitabine ready-to-use | Ovarian cancer | Sun Pharmaceutical Industries Ltd.;Acme Plaza, Andheri (East), Mumbai 400059; | June 24, 2015 | |
Volanesorsen sodium, apolipotrotein C-III antisense oligonucleotide | Hyperlipoproteinemia type 1 | Akcea Therapeutics, Inc.;55 Cambridge Parkway, Suite 100;Cambridge, Massachusetts, 02142 | June 23, 2015 | |
2-{3-[(3R)-3-({[2-chloro-3-(trifluoromethyl)phenyl]methyl}(2,2-diphenylethyl)amino)butoxy]phenyl}acetic acid | Malignant melanoma stages IIB to IV | Rgenix, Inc.;310 East 67th St., Suite 1-12;New York, New York, 10065 | June 23, 2015 | |
Chlorotoxin conjugated to indocyanine green dye | Diagnostic for the management of malignant brain tumors | Blaze Bioscience, Inc.;530 Fairview Avenue, North, Suite 1400;Seattle, Washington, 98109 | June 23, 2015 | |
(1OR)-7-amino-12-fluoro-2,10,16-trimethyl-15 oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile | Non-small cell lung cancer | Pfizer, Inc.;235 East 42nd Street (M/S 219/9/30);New York, New York, 10017 | June 23, 2015 | |
Antisense oligonucleotide directed against TGF-beta2 mRNA | Prevention of scarring post glaucoma filtration surgery | Isarna Therapeutics GmbH | June 19, 2015 | |
6-ethoxy-7-methoxy-2-(2-methylsulfanylphenyl)-3,1-bensoxazin-4-one | Netherton syndrome | Sixera Pharma AB;Erik Dahlbergsgaten 11a2t, Vastra Gotaland 41126; | June 18, 2015 | |
Pembrolizumab | Gastric cancer, including gastroesophageal junction adenocarcinoma | Merck Research Laboratories;351 North Sumneytown Pike, UG2C-50;North Wales, Pennsylvania, 19454 | June 16, 2015 | |
2-{3-[(3R)-3-({[2-chloro-3-(trifluoromethyl)phenyl]methyl}(2,2-diphenylethyl)amino)butoxy]phenyl}acetic acid | Glioblastoma | Rgenix, Inc.;310 East 67th St., Suite 1-12;New York, New York, 10065 | June 16, 2015 | |
2-{3-[(3R)-3-({[2-chloro-3-(trifluoromethyl)phenyl]methyl}(2,2-diphenylethyl)amino)butoxy]phenyl}acetic acid | Ovarian cancer | Rgenix, Inc.;310 East 67th St., Suite 1-12;New York, New York, 10065 | June 16, 2015 | |
Synthetic signal peptide of human mucin-1 (amino acids 1-21) | Multiple myeloma | Vaxil Bio Therapeutics Ltd.;13 Einstein St., Building 13A, Nes-Ziona 7414001; | June 16, 2015 | |
Recombinant adeno-associated virus serotype rhesus 74 (rh74) expressing the human CT GalNac transferase (GALGT2) gene, also called the Sda or Cad GAlNac transferase or b4Galnt2, under control of the muscle creatine kinase (MCK) promoter | Duchenne muscular dystrophy | Nationwide Children's Hospital;700 Children's Drive, Rm WA2025;Columbus, Ohio, 43205 | June 16, 2015 | |
Imetelstat | Myelofibrosis | Janssen Research & Development, LLC;P. O. Box 300, 920 US Route 202;Raritan, New Jersey, 08869 | June 11, 2015 | |
(6aR, 10aR)-3-(1’,1’-dimethylheptyl)-Δ8-tetrahydro-cannabinol-9-carboxylic acid | Systemic sclerosis | Corbus Pharmaceuticals, Inc.;100 River Ridge Drive, Suite 103;Norwood, MA, 02062 | June 10, 2015 |